Anbio Biotechnology (NNNN) Operating margin 2022–2025
Anbio Biotechnology (NNNN) operating margin by fiscal year — reported operating income divided by reported revenue.
66.7%FY2025 · since FY2022: 43.3% → 66.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 66.7% | +42.3 pp |
| FY2024 | 24.4% | -4.8 pp |
| FY2023 | 29.2% | -14.1 pp |
| FY2022 | 43.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice